{"title":"An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA06237J","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA06237J\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,30487-30517<br /><b>DOI</b>: 10.1039/D4RA06237J, Review Article</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Shivani Kirad, Sonakshi Puri, P. R. Deepa, Murugesan Sankaranarayanan<br />SCD1 inhibitors block the conversion of saturated to monounsaturated fatty acids, reducing lipid accumulation, desaturation index, fat mass, and lipotoxicity. They are promising for treating various metabolic disorders.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"3b2807a9b824e13501f625a0dc80f9a7134154de03bfb19ea932b0ee240b4c47","category":"Environment"}